Purchase Order AG5615P160091
- Not listed
- Illumina, Inc. has been awarded a purchase order valued at $89,930.78 for annual MiSeq support and maintenance services, with an ultimate completion date of October 27, 2029. The contract, awarded on August 12, 2024, by the Office of Acquisitions and Grants, utilizes firm fixed pricing with no set-aside designation. Performance will take place in Honolulu, Hawaii. The MiSeq is a mid-throughput genomic sequencing instrument widely used in research and diagnostic applications, and this contract...
- Illumina, Inc. was awarded a firm fixed-price contract valued at $10,720.61 for maintenance services on a MiSeq DNA sequencer at a civilian federal facility in Peoria, Illinois. The contract was issued on January 19, 2016, as a Blanket Purchase Agreement (BPA) call with a period of performance from January 17, 2016, through September 30, 2016. No set-aside designation was applied to this award, reflecting Illumina's specialized technological capabilities in genomic sequencing equipment...
- This is a firm fixed-price purchase order awarded by the Office of Acquisitions and Grants, a civilian agency, to Illumina, Inc., a manufacturer of genomic sequencing instruments and solutions. The contract is for $71,643.00 to provide service maintenance for an Illumina MiSeq sequencer. The award has no set-aside designation and the period of performance runs through June 10, 2024. Illumina has a history of providing sequencing systems and related services to various government agencies,...
- Illumina, Inc. was awarded a $4,800 firm fixed price purchase order (CAT# SP-103-1004) for Product Care MiSeq Preventative maintenance services, with an ultimate completion date of August 31, 2019. The contract was awarded on August 28, 2018, with no set-aside designation applied. The place of performance is located in San Diego, California, where Illumina maintains its headquarters. Funding was provided by a civilian federal agency within the Midwest Area. This purchase order represents a...
- Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a delivery order valued at $15,349.28 for MiSeq Silver Support Plan maintenance services on a MiSeq sequencing instrument (serial number M01098) located in Ames, Iowa. The contract, awarded on December 16, 2025, carries a firm fixed price structure with an ultimate completion date of December 15, 2026. This delivery order does not utilize a set-aside designation,...
- This is a firm fixed-price service contract awarded by the U.S. Department of Agriculture (USDA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for a Comprehensive Maintenance Plan for Illumina's MiSeq sequencing system, with a ceiling value of $16,285 and a period of performance through March 16, 2019. The award does not utilize any set-aside designations. Illumina has previously received other prime federal contracts and subcontracts from...
- This is a firm fixed-price contract awarded by the Midwest Area division of a civilian federal agency to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for a maintenance agreement and support plan for a MiSeq DNA sequencer, with a ceiling value of $12,875.00 and a period of performance through July 31, 2019. The contract was awarded on a sole-source basis, with no set-aside designation. Illumina has a history of providing genetic sequencing systems...
- This contract award is a Blanket Purchase Agreement (BPA) call issued to Illumina, Inc. for the MiSeq Basic Plan product care service, valued at $13,371.25 under a firm fixed-price arrangement. The award was made on October 12, 2016, with an ultimate completion date of September 30, 2017, and does not utilize a set-aside designation. The contracting activity is under a civilian federal agency identified as the Midwest Area, with the place of performance located in Peoria, Illinois. Illumina, a...
- This is a firm fixed price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents. The contract, valued at $13,000.00, is for a MiSeq Standard Service Contract to provide maintenance and support for a MiSeq sequencing system. The contract has no set-aside designation. Illumina has a...
- This is a firm fixed price delivery order contract awarded to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents, to provide a support plan for an Illumina MiSeq sequencing instrument. The $15,145.13 contract was awarded by the Plains Area division of an unnamed civilian federal agency. Illumina has previously provided a range of sequencing systems and related goods and services to support research and diagnostics at agencies like the NIH, CDC, USDA, and...
Illumina, Inc. was awarded a firm fixed-price purchase order valued at $15,470.75 for a DNA Sequencer MiSeq Comprehensive Plan annual service contract with quarterly payments. The contract, which was awarded on May 6, 2016, with an ultimate completion date of May 9, 2017, covers product care and maintenance services for the MiSeq sequencing instrument. The place of performance is located in San Diego, California, and the contract was funded by a civilian federal agency within the Midwest Area. No set-aside designation was used for this procurement, reflecting Illumina's specialized capabilities in genomic sequencing technologies. This contract represents a service and maintenance agreement for Illumina's MiSeq sequencing platform, a widely adopted instrument in federal research facilities. The MiSeq is utilized across multiple civilian agencies for genomic analysis applications including research, diagnostics, and environmental monitoring. The quarterly payment structure provides the federal agency with comprehensive product care coverage, ensuring optimal instrument performance and uptime for critical genomic research operations. As a parent contract, this award is consistent with Illumina's extensive portfolio of federal contracts with agencies such as the National Institutes of Health, Centers for Disease Control and Prevention, and the Department of Agriculture.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 5/6/16 |